常染色体显性RP1 c.2613dupA (p.Arg872Thrfs*2)变异色素性视网膜炎显示椭球区随时间线性丧失,表型高度可变。

IF 2.1 4区 医学 Q2 OPHTHALMOLOGY
Ophthalmologica Pub Date : 2025-04-01 DOI:10.1159/000545606
Nastasia Foa, Maximilian Pfau, Georg Ansari, Giuseppe Cancian, Gabriela Grimaldi, Samuel Koller, Wolfgang Berger, Pascal Escher, Lucas Janeschitz-Kriegl, Carlo Rivolta, Hendrik P N Scholl, Moreno Menghini
{"title":"常染色体显性RP1 c.2613dupA (p.Arg872Thrfs*2)变异色素性视网膜炎显示椭球区随时间线性丧失,表型高度可变。","authors":"Nastasia Foa, Maximilian Pfau, Georg Ansari, Giuseppe Cancian, Gabriela Grimaldi, Samuel Koller, Wolfgang Berger, Pascal Escher, Lucas Janeschitz-Kriegl, Carlo Rivolta, Hendrik P N Scholl, Moreno Menghini","doi":"10.1159/000545606","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>To report the phenotype and progression pattern of RP1 retinitis pigmentosa carrying the variant c.2613dupA (p.Arg872Thrfs*2).</p><p><strong>Methods: </strong>Retrospective chart review and prospective cohort study from 13 families with confirmed RP1 c.2613dupA (p.Arg872Thrfs*2) variant. Analysis was performed on clinical data including multimodal imaging and visual function tests. Progression rate was defined as the length of ellipsoid zone lost per year and was calculated for all patients. Linear mixed model to predict the diameter of EZ loss as a function of age was applied.</p><p><strong>Results: </strong>21 patients were included in the study. EZ loss in all patients ranged from 3.8 to 576.0 µm/year (median PR 76.5, IQR 97.6) in right eyes, and from 26.6 to 340.7 µm/year (median PR 96.6, IQR 70.3), in left eyes, respectively with a linear slope of progression for both eyes. The linear mixed model using age as an explanatory variable explained 25% of the variability in PR, and showed that male patients had on average a statistically significant smaller EZ diameter at baseline.</p><p><strong>Discussion: </strong>The rate of progression of RP1 as measured by loss of EZ appears to be linear, independent of the age of onset. Furthermore, it appears that male subjects may present with earlier onset of disease as they showed a statistically significant smaller EZ diameter at baseline. Monitoring of EZ loss could be a valid clinical surrogate marker for clinical trials, but possibly sex differences and high variability of phenotypes need to be considered.</p>","PeriodicalId":19595,"journal":{"name":"Ophthalmologica","volume":" ","pages":"1-16"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Autosomal dominant RP1 c.2613dupA (p.Arg872Thrfs*2) variant retinitis pigmentosa shows linear loss of the ellipsoid zone over time with highly variable phenotype.\",\"authors\":\"Nastasia Foa, Maximilian Pfau, Georg Ansari, Giuseppe Cancian, Gabriela Grimaldi, Samuel Koller, Wolfgang Berger, Pascal Escher, Lucas Janeschitz-Kriegl, Carlo Rivolta, Hendrik P N Scholl, Moreno Menghini\",\"doi\":\"10.1159/000545606\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>To report the phenotype and progression pattern of RP1 retinitis pigmentosa carrying the variant c.2613dupA (p.Arg872Thrfs*2).</p><p><strong>Methods: </strong>Retrospective chart review and prospective cohort study from 13 families with confirmed RP1 c.2613dupA (p.Arg872Thrfs*2) variant. Analysis was performed on clinical data including multimodal imaging and visual function tests. Progression rate was defined as the length of ellipsoid zone lost per year and was calculated for all patients. Linear mixed model to predict the diameter of EZ loss as a function of age was applied.</p><p><strong>Results: </strong>21 patients were included in the study. EZ loss in all patients ranged from 3.8 to 576.0 µm/year (median PR 76.5, IQR 97.6) in right eyes, and from 26.6 to 340.7 µm/year (median PR 96.6, IQR 70.3), in left eyes, respectively with a linear slope of progression for both eyes. The linear mixed model using age as an explanatory variable explained 25% of the variability in PR, and showed that male patients had on average a statistically significant smaller EZ diameter at baseline.</p><p><strong>Discussion: </strong>The rate of progression of RP1 as measured by loss of EZ appears to be linear, independent of the age of onset. Furthermore, it appears that male subjects may present with earlier onset of disease as they showed a statistically significant smaller EZ diameter at baseline. Monitoring of EZ loss could be a valid clinical surrogate marker for clinical trials, but possibly sex differences and high variability of phenotypes need to be considered.</p>\",\"PeriodicalId\":19595,\"journal\":{\"name\":\"Ophthalmologica\",\"volume\":\" \",\"pages\":\"1-16\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000545606\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545606","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

前言:报道携带c.2613dupA变异的RP1视网膜色素变性的表型和进展模式(p.Arg872Thrfs*2)。方法:对13个RP1 c.2613dupA (p.Arg872Thrfs*2)变异家族进行回顾性分析和前瞻性队列研究。对临床资料进行分析,包括多模态成像和视觉功能测试。进展率定义为每年丢失的椭球区长度,并计算所有患者的进展率。采用线性混合模型预测EZ损耗直径随时间的变化。结果:21例患者纳入研究。所有患者的右眼EZ损失范围为3.8 - 576.0µm/年(中位PR为76.5,IQR为97.6),左眼EZ损失范围为26.6 - 340.7µm/年(中位PR为96.6,IQR为70.3),两眼分别呈线性斜率进展。使用年龄作为解释变量的线性混合模型解释了25%的PR变异性,并显示男性患者在基线时平均EZ直径较小,具有统计学意义。讨论:通过EZ丧失测量的RP1进展率似乎是线性的,与发病年龄无关。此外,男性受试者可能出现较早发病,因为他们在基线时显示具有统计学意义的较小的EZ直径。监测EZ损失可能是临床试验的有效临床替代标志物,但可能需要考虑性别差异和表型的高变异性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Autosomal dominant RP1 c.2613dupA (p.Arg872Thrfs*2) variant retinitis pigmentosa shows linear loss of the ellipsoid zone over time with highly variable phenotype.

Introduction: To report the phenotype and progression pattern of RP1 retinitis pigmentosa carrying the variant c.2613dupA (p.Arg872Thrfs*2).

Methods: Retrospective chart review and prospective cohort study from 13 families with confirmed RP1 c.2613dupA (p.Arg872Thrfs*2) variant. Analysis was performed on clinical data including multimodal imaging and visual function tests. Progression rate was defined as the length of ellipsoid zone lost per year and was calculated for all patients. Linear mixed model to predict the diameter of EZ loss as a function of age was applied.

Results: 21 patients were included in the study. EZ loss in all patients ranged from 3.8 to 576.0 µm/year (median PR 76.5, IQR 97.6) in right eyes, and from 26.6 to 340.7 µm/year (median PR 96.6, IQR 70.3), in left eyes, respectively with a linear slope of progression for both eyes. The linear mixed model using age as an explanatory variable explained 25% of the variability in PR, and showed that male patients had on average a statistically significant smaller EZ diameter at baseline.

Discussion: The rate of progression of RP1 as measured by loss of EZ appears to be linear, independent of the age of onset. Furthermore, it appears that male subjects may present with earlier onset of disease as they showed a statistically significant smaller EZ diameter at baseline. Monitoring of EZ loss could be a valid clinical surrogate marker for clinical trials, but possibly sex differences and high variability of phenotypes need to be considered.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ophthalmologica
Ophthalmologica 医学-眼科学
CiteScore
5.10
自引率
3.80%
发文量
39
审稿时长
3 months
期刊介绍: Published since 1899, ''Ophthalmologica'' has become a frequently cited guide to international work in clinical and experimental ophthalmology. It contains a selection of patient-oriented contributions covering the etiology of eye diseases, diagnostic techniques, and advances in medical and surgical treatment. Straightforward, factual reporting provides both interesting and useful reading. In addition to original papers, ''Ophthalmologica'' features regularly timely reviews in an effort to keep the reader well informed and updated. The large international circulation of this journal reflects its importance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信